|
1
|
Han B, Zheng R, Zeng H, Wang S, Sun K,
Chen R, Li L, Wei W and He J: Cancer incidence and mortality in
China, 2022. J Natl Cancer Cent. 4:47–53. 2024.PubMed/NCBI
|
|
2
|
Yang XB, Zhang LH, Xue JN, Wang YC, Yang
X, Zhang N, Liu D, Wang YY, Xun ZY, Li YR, et al: High incidence
combination of multiple primary malignant tumors of the digestive
system. World J Gastroenterol. 28:5982–5992. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wan Y, Wang Z, Yang N and Liu F: Treatment
of multiple primary malignancies with PD-1 inhibitor camrelizumab:
A case report and brief literature review. Front Oncol.
12:9119612022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berek JS, Matias-Guiu X, Creutzberg C,
Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D and Concin
N; Endometrial Cancer Staging Subcommittee and FIGO Women's Cancer
Committee, : FIGO staging of endometrial cancer: 2023. Int J
Gynaecol Obstet. 162:383–394. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nicholls RJ, Zinicola R and Haboubi N:
Extramural spread of rectal cancer and the AJCC Cancer Staging
Manual 8th edition, 2017. Ann Oncol. 30:1394–1395. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Waldmann A, Borchers P and Katalinic A:
Temporal trends in age- and stage-specific incidence of colorectal
adenocarcinomas in Germany. BMC Cancer. 23:11802023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kong BH, Song K and Yin AJ: Prevention and
treatment of endometrial cancer. Zhonghua Yi Xue Za Zhi.
104:715–720. 2024.(In Chinese). PubMed/NCBI
|
|
8
|
Ramirez PT, Frumovitz M, Pareja R, Lopez
A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N, et al:
Minimally invasive versus abdominal radical hysterectomy for
cervical cancer. N Engl J Med. 379:1895–1904. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi HJ and Lee JH: Multiple human
papilloma virus 16 infection presenting as various skin lesions. J
Craniofac Surg. 27:e379–e381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ribeiro MF, Peretz Soroka H, Bhura Z,
Hirsch I, Wunder J, Ferguson P, Tsoi K, Brar S, Gladdy R, Swallow
C, et al: Clinico-demographic characteristics and outcomes of
radiation-induced sarcomas (RIS): A CanSaRCC study. Ther Adv Med
Oncol. 15:175883592311989432023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roberts NT, MacDonald CR, Mohammadpour H,
Antoch MP and Repasky EA: Circadian rhythm disruption increases
tumor growth rate and accumulation of Myeloid-derived suppressor
cells. Adv Biol (Weinh). 6:e22000312022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim TH, Kim JH, Kang CH, Keam B and Kim
HJ: Treatment of Fanconi anemia patient with synchronous esophageal
and tongue cancer in COVID-19 era: A case report. Radiat Oncol J.
42:83–87. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yatsuoka T, Fukumitsu H, Kita T, Kitaoka
M, Otsuki T and Suzuki S: A case of synchronous papillary thyroid
cancer and breast ductal cancer. Gan To Kagaku Ryoho. 51:220–222.
2024.(In Japanese). PubMed/NCBI
|
|
14
|
Damaskos C, Dimitroulis D, Garmpi A,
Antoniou EA, Kouraklis G, Psilopatis I, Mavri M, Diamantis E,
Marinos G and Kyriakos G: Synchronous insulinoma and glucagonoma: A
Review of the literature. In Vivo. 37:2402–2408. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang F, Xu P, Yue Z, Song Y, Hu K, Zhao
X, Gao M and Chong Z: Body weight correlates with molecular
variances in patients with cancer. Cancer Res. 84:757–770. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Minalt N, Caldwell A, Yedlicka GM, Joseph
S, Robertson SE, Landrum LM and Peipert JF: Association between
intrauterine device use and endometrial, cervical, and ovarian
cancer: An expert review. Am J Obstet Gynecol. 229:93–100. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Z, Jin C, Zhang Y, Wang J and Zheng L:
Identification of BRAF, CCND1, and MYC mutations in a patient with
multiple primary malignant tumors: A case report and review of the
literature. World J Surg Oncol. 21:1582023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bogani G, Tibiletti MG, Ricci MT,
Carnevali I, Liberale V, Paolini B, Milione M, Vitellaro M, Murgia
F and Chiappa V: Lynch syndrome-related non-endometrioid
endometrial cancer: Analysis of outcomes. Int J Gynecol Cancer.
30:56–61. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Valencia Cardona AF, Cruz Barbosa JS and
Cortés Buelvas A: Synchronous adenocarcinoma of the endometrium and
colon in a woman with Lynch syndrome associated with a mutation of
the MSH6 gene. Rev Esp Patol. 58:1008262025.PubMed/NCBI
|
|
20
|
Wang L, Wei W and Cai M: A Review of the
risk factors associated with endometrial hyperplasia during
perimenopause. Int J Womens Health. 16:1475–1482. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang L, Fei H, Yang A, Zhu J, Sun J, Liu
X, Xu W, Yang J and Zhang S: Estrogen inhibits the growth of colon
cancer in mice through reversing extracellular Vesicle-mediated
immunosuppressive tumor microenvironment. Cancer Lett. 520:332–343.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Williams C, DiLeo A, Niv Y and Gustafsson
JÅ: Estrogen receptor beta as target for colorectal cancer
prevention. Cancer Lett. 372:48–56. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brändstedt J, Wangefjord S, Nodin B,
Eberhard J, Jirström K and Manjer J: Associations of hormone
replacement therapy and oral contraceptives with risk of colorectal
cancer defined by clinicopathological factors, beta-catenin
alterations, expression of cyclin D1, p53, and
microsatellite-instability. BMC Cancer. 14:3712014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gilligan LC, Rahman HP, Hewitt AM, Sitch
AJ, Gondal A, Arvaniti A, Taylor AE, Read ML, Morton DG and Foster
PA: Estrogen activation by steroid sulfatase increases colorectal
cancer proliferation via GPER. J Clin Endocrinol Metab.
102:4435–4447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ni S, Wang X, Chang J, Sun H, Weng W, Wang
X, Tan C, Zhang M, Wang L, Huang Z, et al: Human epidermal growth
factor receptor 2 overexpression and amplification in patients with
colorectal cancer: A Large-scale retrospective study in Chinese
population. Front Oncol. 12:8427872022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Underwood PW, Ruff SM and Pawlik TM:
Update on targeted therapy and immunotherapy for metastatic
colorectal cancer. Cells. 13:2452024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akizawa Y, Kanno T, Horibe Y, Shimizu Y,
Noguchi E, Yamamoto T, Okamoto T, Nagashima Y and Tabata T: Ovarian
metastasis from breast cancer mimicking a primary ovarian neoplasm:
A case report. Mol Clin Oncol. 15:1352021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao Y, Liu J and Zhou X, Liu Z, Qiu S, He
Y and Zhou X: A pan-cancer analysis of TTC9A expression level and
its correlation with prognosis and immune microenvironment. Nan
Fang Yi Ke Da Xue Xue Bao. 44:70–82. 2024.(In Chinese). PubMed/NCBI
|
|
29
|
Qureshi MA, Khan S, Tauheed MS, Syed SA,
Ujjan ID, Lail A and Sharafat S: Pan-cancer multiomics analysis of
TC2N gene suggests its important role(s) in tumourigenesis of many
cancers. Asian Pac J Cancer Prev. 21:3199–3209. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Munro D, Ghersi D and Singh M: Two
critical positions in zinc finger domains are heavily mutated in
three human cancer types. PLoS Comput Biol. 14:e10062902018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv M, Zhang X, Shen Y, Wang F and Yang J,
Wang B, Chen Z, Li P, Zhang X, Li S and Yang J: Clinical analysis
and prognosis of synchronous and metachronous multiple primary
malignant tumors. Medicine (Baltimore). 96:e67992017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Jiao F, Yao J, Zhou X, Zhang X and
Wang L: Clinical features of multiple primary malignant tumors: A
retrospective clinical analysis of 213 Chinese patients at two
centers. Discov Med. 32:65–78. 2021.PubMed/NCBI
|
|
33
|
Mir AW, Parveen S, Ahmad I, Naveed S, Syed
NA, Mohmad HM and Dar N: Multiple primary malignancies: A
clinicopathological profile of patients at a tertiary center of
North India-A retrospective Hospital-Based observational study.
Indian J Med Paediatr Oncol. 45:052–060. 2023.
|
|
34
|
Edamadaka Y, Parghane RV and Basu S:
Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in evaluating
synchronous thyroid carcinoma and parathyroid adenoma with brown
tumors. World J Nucl Med. 23:220–224. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu N, Gao Y, Pan Y, Song L, Yang Y, Yin
Y, Wang Y, Zhang L, Wu S and Yu G: Clinical analysis of lymphoma
with malignant solid tumor simultaneously: A retrospective case
series. Diagn Pathol. 20:542025. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kremzer T, Pete I, Ruttner P, Csucska M
and Lóderer Z: Synchronous tumor treatment in the presence of
gynecologycal cancer in three patients. Orv Hetil. 164:70–75. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Macciò A, Lavra F, Chiappe G, Kotsonis P,
Sollai G, Zamboni F and Madeddu C: Combined laparoscopic excisional
surgery for synchronous endometrial and rectal adenocarcinoma in an
obese woman. J Obstet Gynaecol. 36:1012–1015. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ferrari F, Soleymani Majd H, Giannini A,
Favilli A, Laganà AS, Gozzini E and Odicino F: Health-related
quality of life after hysterectomy for endometrial cancer: The
impact of enhanced recovery after surgery shifting paradigm.
Gynecol Obstet Invest. 89:304–310. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mihăilescu AA, Onisâi M, Alexandru A,
Teodorescu M, Aliuș C, Blendea CD, Neagu ȘI, Șerban D and Grădinaru
S: A comparative analysis between enhanced recovery after surgery
and traditional care in the management of obstructive colorectal
cancer. Medicina (Kaunas). 60:13192024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakanishi K, Goto W, Ishihara A, Tauchi J,
Kashiwagi S, Amano R, Kubo S and Ohira M: A case of synchronous
double cancer including borderline resectable pancreatic body
cancer and breast carcinoma with Osseous/cartilaginous
differentiation treated with neoadjuvant chemotherapy and radical
resection. Gan To Kagaku Ryoho. 48:2005–2007. 2021.(In Japanese).
PubMed/NCBI
|
|
41
|
Di Franco DS, Chiloiro G, Savino M,
Costamagna I, Romano A, Meldolesi E, Damiani A and Valentini V:
3057: Clinical impact of ESMO guidelines adherence in rectal
cancer: A process mining of real world. Radiotherapy Oncol. 194
(Suppl):S1566–S1568. 2024. View Article : Google Scholar
|
|
42
|
Oaknin A, Bosse TJ, Creutzberg CL,
Giornelli G, Harter P, Joly F, Lorusso D, Marth C, Makker V, Mirza
MR, et al: Endometrial cancer: ESMO clinical practice guideline for
diagnosis, treatment and follow-up. Ann Oncol. 33:860–877. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ye S, Zhou S, Zhong S, Shan B, Jiang W,
Yang W, Cai X and Yang H: The frequency and clinical implication of
mismatch repair protein deficiency in Chinese patients with ovarian
clear cell carcinoma. BMC Cancer. 22:4492022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Virga A, Gianni C, Palleschi M, Angeli D,
Merloni F, Maltoni R, Ulivi P, Martinelli G, De Giorgi U and
Bravaccini S: A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS
Assay: A Non-invasive tool to monitor resistance mechanisms to
hormonal therapy and CDK4/6 inhibitors. Biomedicines. 12:21832024.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yin H, Zhang M, Zhang Y, Zhang X, Zhang X
and Zhang B: Liquid biopsies in cancer. Mol Biomed. 6:182025.
View Article : Google Scholar : PubMed/NCBI
|
